Galactic AI™
Use cases
Knowledge Graphs
Build better knowledge graphs with millions of novel high quality cause-and-effect relationships and contextual data
MoA & Explainability
Novel evidence to explain diseases and hypothesise treatment approaches
Biomarker Selection
Identify novel pharmacodynamic biomarkers from > 40 million documents
Target Selection
Infer drug-target-disease cause-and-effect relationships to ID novel targets and validate existing hypotheses
Indication Expansion
Use data annotations to identify diseases directly connected to a target based on well-established literature evidence
Knowledge Reviews
Systematically retrieve all relevant information to support go/no-go decisions
Case studies & benchmarks
Company
Galactic Web login
Request demo
Galactic Web login
Request demo
News
Foundations for Change: A Framework for Transforming R&D Outcomes With AI
Foundations for Change: A Framework for Transforming R&D Outcomes With AI
Dr Ben Sidders
July 16, 2025
•
5 min read
Share this post
Biorelate News
Latest News
Discover new insights and updates for data science in biopharma
View all
Galactic Data 3.0: The Future of AI for R&D?
Biorelate announces the release of Galactic Data 3.0.
Accelerating drug discovery innovation via advanced data science solutions – a case study of Almirall (global pharma company) and Biorelate (data science solutions provider)
Pharma Almirall enlisted Biorelate, with its cutting-edge AI platform, Galactic AI™, to help accelerate their R&D innovation and productivity.
Unlocking the Power of Data in AI-Driven Drug Discovery
To unlock the true potential of Artificial Intelligence, pharma companies must adopt a robust data strategy, generating and harmonising data specifically for AI applications
View all
